Literature DB >> 8098618

Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.

R Costello1, C Lipcey, M Algarté, C Cerdan, P A Baeuerle, D Olive, J Imbert.   

Abstract

Stimulation of highly purified human T-cells via CD2 and CD28 adhesion molecules induces and maintains proliferation for more than 3 weeks. This potent interleukin 2 (IL-2)-dependent activation does not require monocytes or accessory cells. Long-lasting IL-2 receptivity is associated with high-level expression of the inducible IL-2 receptor alpha chain (IL-2R alpha) gene that is regulated at both transcriptional and posttranscriptional levels. Increase of IL-2R alpha gene transcription involves the enhanced binding of the transcription factor NF-kappa B to its consensus sequence in the 5'-regulatory region of the IL-2R alpha gene. To dissect the molecular basis for the unusually persistent transcription of the IL-2R alpha gene, we analyzed nuclear NF-kappa B binding to a radiolabeled IL-2R alpha kappa B-specific oligonucleotide probe during the time course of CD2 + CD28 activation. Resting T-cell nuclear extracts contained KBF1/p50 homodimer. After stimulation, two new kappa B-specific complexes were identified as NF-kappa B p50-p65 heterodimer and putative c-Rel homodimer or c-Rel-p65 heterodimer. Both inducible complexes persisted for at least 3 weeks. Their relative levels were very similar for the duration of proliferation. In parallel, CD2 + CD28 activation triggered a significant intracellular thiol decrease, suggesting that oxygen radicals are involved in the signaling pathway of adhesion molecules. Finally, micromolar amounts of pyrrolidine dithiocarbamate, an oxygen radical scavenger that efficiently blocked the nuclear appearance of NF-kappa B in T-lymphocytes, also inhibited IL-2 secretion, IL-2R alpha cell surface expression, and T-cell proliferation. Together, these results suggest that NF-kappa B plays an important role in long-term activation of human primary T-lymphocytes via CD2 + CD28.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098618

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  15 in total

1.  Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus.

Authors:  J H Yeh; P Lecine; J A Nunes; S Spicuglia; P Ferrier; D Olive; J Imbert
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product.

Authors:  Z L Chu; T A McKinsey; L Liu; X Qi; D W Ballard
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

3.  TCRalpha enhancer activation occurs via a conformational change of a pre-assembled nucleo-protein complex.

Authors:  S Spicuglia; D Payet; R K Tripathi; P Rameil; C Verthuy; J Imbert; P Ferrier; W M Hempel
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

4.  Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells.

Authors:  R G Bryan; Y Li; J H Lai; M Van; N R Rice; R R Rich; T H Tan
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

5.  Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.

Authors:  Sophie Reuse; Miriam Calao; Kabamba Kabeya; Allan Guiguen; Jean-Stéphane Gatot; Vincent Quivy; Caroline Vanhulle; Aurélia Lamine; Dolores Vaira; Dominique Demonte; Valérie Martinelli; Emmanuelle Veithen; Thomas Cherrier; Véronique Avettand; Solène Poutrel; Jacques Piette; Yvan de Launoit; Michel Moutschen; Arsène Burny; Christine Rouzioux; Stéphane De Wit; Georges Herbein; Olivier Rohr; Yves Collette; Olivier Lambotte; Nathan Clumeck; Carine Van Lint
Journal:  PLoS One       Date:  2009-06-30       Impact factor: 3.240

6.  Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress.

Authors:  C Berruyer; F M Martin; R Castellano; A Macone; F Malergue; S Garrido-Urbani; V Millet; J Imbert; S Duprè; G Pitari; P Naquet; F Galland
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

7.  Low CD3+CD28-induced interleukin-2 production correlates with decreased reactive oxygen intermediate formation in neonatal T cells.

Authors:  S Kilpinen; M Hurme
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

8.  Inhibition of activation of transcription factor AP-1 by CD28 signalling in human T-cells.

Authors:  M Los; W Dröge; K Schulze-Osthoff
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

9.  In vivo regulation of interleukin-2 receptor alpha gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells.

Authors:  M Algarté; P Lécine; R Costello; A Plet; D Olive; J Imbert
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

10.  RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A.

Authors:  M Neumann; T Grieshammer; S Chuvpilo; B Kneitz; M Lohoff; A Schimpl; B R Franza; E Serfling
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.